EFFECT OF CYCLOPHOSPHAMIDE ON LEUKOCYTIC SUBSET DISTRIBUTIONS IN RATS CARRYING THE DUNNING R3327-MAT-LYLU PROSTATIC ADENOCARCINOMA
EFFECT OF CYCLOPHOSPHAMIDE ON LEUKOCYTIC SUBSET DISTRIBUTIONS IN RATS CARRYING THE DUNNING R3327-MAT-LYLU PROSTATIC ADENOCARCINOMA
复制标题
DOI:
10.1002/pros.2990110203
复制
发表时间:
1987-01-01
期刊:
影响因子:
2.8
通讯作者:
GUINAN, PD
中科院分区:
文献类型:
--
作者:
SHAW, MW;RUBENSTEIN, M;GUINAN, PD
The Dunning R3327 adenocarcinoma represents a model for studying prostate cancer in rats; early studies have indicated its utility for studying relationship between tumor growth, immunologic markers, and chemotherapy. Normal animals and those bearing the metastatic Dunning R3327 MAT-LyLu tumor were treated with 10, 30, and 100 mg/kg doses of cyclophosphamide (CTX) and their spleens assayed for leukocytic subset distributions using monoclonal antibodies. Tumor-bearing animals had significant reductions in helper T cell content as well as reduced helper/suppressor T cell ratios, compared to controls. These effects occurred rapidly following implantation and were not reversed by chemotherapy. When administered to both tumor- and non-tumor-bearing animals, CTX also depleted T cell populations. Despite reductions produced in all subsets, two administrations of CTX (30 mg/kg) were capable of retaining (in non-tumor-bearing animals) or restoring (in tumor-bearing) normal helper/suppressor T cell ratios. Such studies aid in identifying therapeutically effective dosages of cytotoxic drugs that minimize their deleterious effects on the immune system.